ALIBABA HLTH INFO.T.HD-01
ALIBABA HLTH INFO.T.HD-01/ BMG0171K1018 /
TWY
|
17/05/2024 16:18:50
|
Chg.
+0.011
|
Volume |
Bid16:18:50 |
Demandez à16:18:50 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
0.384EUR
|
+2.95%
|
-
Chiffrre d'affaires: - |
0.384Bid taille: - |
0.393Ask la taille: - |
5.32 Mrd.EUR |
- |
- |
Description de l'entreprise
Alibaba Health Information Technology Limited engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Conseil d'administration & Conseil de surveillance
| PDG |
| Zhu Shunyan |
| Conseil d'administration |
| Tu Yanwu, Shen Difan, Zhang Hua, Yin Rui, Deng Yan |
| Conseil de surveillance |
| Zhu Shunyan, Shen Difan, Tu Yanwu, Huang Jiaojiao, Dr. Shao Rong, Wu May Yihong, Huang Yi Fei, (Vanessa), Xu Haipeng |
Données de l'entreprise
| Nom: |
Alibaba Health Information Technology Ltd |
| Adresse: |
Tower One, 26th Floor Times Square 1 Matheson Street,Causeway Bay, Hong Kong |
| Téléphone: |
+86-852-2215-5100 |
| Fax: |
+86-852-2215-5200 |
| Courriel: |
alihealth_info@alibaba-inc.com
|
| Internet: |
https://www.alihealth.cn/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/03 |
| Flotte libre: |
- |
| IPO date: |
06/07/1972 |
